US4187852A
(en)
|
1976-07-09 |
1980-02-12 |
The University Of Alabama |
Synthetic elastomeric insoluble cross-linked polypentapeptide
|
US4132746A
(en)
|
1976-07-09 |
1979-01-02 |
University Of Alabama, Birmingham Medical & Education Foundation |
Synthetic elastomeric insoluble cross-linked polypentapeptide
|
US4474851A
(en)
|
1981-10-02 |
1984-10-02 |
The University Of Alabama In Birmingham |
Elastomeric composite material comprising a polypeptide
|
US4500700A
(en)
|
1981-10-02 |
1985-02-19 |
The Board Of Trustees Of The University Of Alabama For The University Of Alabama In Birmingham |
Elastomeric composite material comprising a polypentapeptide having an amino acid of opposite chirality in position three
|
US4589882A
(en)
|
1983-09-19 |
1986-05-20 |
Urry Dan W |
Enzymatically crosslinked bioelastomers
|
US4752638A
(en)
|
1983-11-10 |
1988-06-21 |
Genetic Systems Corporation |
Synthesis and use of polymers containing integral binding-pair members
|
US4749647A
(en)
|
1984-06-22 |
1988-06-07 |
Genetic Systems Corporation |
Polymerization-induced separation assay using recognition pairs
|
US4605641A
(en)
*
|
1984-10-09 |
1986-08-12 |
Hoffmann-La Roche Inc. |
Synthetic vasoactive intestinal peptide analogs
|
US4734400A
(en)
|
1984-10-09 |
1988-03-29 |
Hoffmann-La Roche Inc. |
Synthetic vasoactive intestinal peptide analogs
|
US4783523A
(en)
|
1986-08-27 |
1988-11-08 |
Urry Dan W |
Temperature correlated force and structure development of elastin polytetrapeptides and polypentapeptides
|
US4870055A
(en)
|
1986-04-17 |
1989-09-26 |
University Of Alabama At Birmingham |
Segmented polypeptide bioelastomers to modulate elastic modulus
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
US4898926A
(en)
|
1987-06-15 |
1990-02-06 |
The University Of Alabama At Birmingham/Research Foundation |
Bioelastomer containing tetra/penta-peptide units
|
US5773249A
(en)
|
1986-11-04 |
1998-06-30 |
Protein Polymer Technologies, Inc. |
High molecular weight collagen-like protein polymers
|
US6018030A
(en)
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
US5830713A
(en)
|
1986-11-04 |
1998-11-03 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
US5514581A
(en)
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
US5243038A
(en)
|
1986-11-04 |
1993-09-07 |
Protein Polymer Technologies, Inc. |
Construction of synthetic DNA and its use in large polypeptide synthesis
|
US5770697A
(en)
|
1986-11-04 |
1998-06-23 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
US5641648A
(en)
|
1986-11-04 |
1997-06-24 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
US6184348B1
(en)
|
1986-11-04 |
2001-02-06 |
Protein Polymer Technologies |
Functional recombinantly prepared synthetic protein polymer
|
US5496712A
(en)
|
1990-11-06 |
1996-03-05 |
Protein Polymer |
High molecular weight collagen-like protein polymers
|
US4835252A
(en)
|
1987-02-26 |
1989-05-30 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Vasoactive intestinal peptide analogs
|
US4939224A
(en)
|
1987-02-26 |
1990-07-03 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Vasoactive intestinal peptide analogs
|
US5606019A
(en)
|
1987-10-29 |
1997-02-25 |
Protien Polymer Technologies, Inc. |
Synthetic protein as implantables
|
IL87055A
(en)
|
1988-07-08 |
1994-06-24 |
Illana Gozes |
Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US5234907A
(en)
*
|
1989-06-30 |
1993-08-10 |
Hoffmann-La Roche Inc. |
Synthetic vasoactive intestinal peptide analogs
|
US5141924A
(en)
|
1989-06-30 |
1992-08-25 |
Hoffmann-La Roche, Inc. |
Synthetic vasoactive intestinal peptide analogs
|
US5447912A
(en)
|
1989-09-18 |
1995-09-05 |
Senetek, Plc |
Erection-inducing methods and compositions
|
US5236904A
(en)
|
1989-09-18 |
1993-08-17 |
Senetek, Plc |
Erection-inducing methods and compositions
|
DE69105323T2
(de)
|
1990-03-27 |
1995-06-01 |
Bioelastics Res Ltd |
Bioelastomeres Arzneimittelabgabesystem.
|
DE69101187T2
(de)
*
|
1990-06-26 |
1994-09-29 |
Sanwa Kagaku Kenkyusho Co |
VIP-Analogen und ihre Verwendung.
|
JPH07108232B2
(ja)
*
|
1990-10-09 |
1995-11-22 |
エム・ディ・リサーチ株式会社 |
ペプチド又は蛋白質の製造方法
|
US5235041A
(en)
|
1990-12-28 |
1993-08-10 |
Protein Polymer Technologies, Inc. |
Purification of structurally ordered recombinant protein polymers
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
US5393602A
(en)
|
1991-04-19 |
1995-02-28 |
Bioelastics Research Ltd. |
Superabsorbent materials and uses thereof
|
JPH05238950A
(ja)
*
|
1991-04-22 |
1993-09-17 |
Sanwa Kagaku Kenkyusho Co Ltd |
易吸収性vip製剤
|
US5958881A
(en)
|
1991-04-25 |
1999-09-28 |
Korman; Louis Y. |
Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
|
AU656230B2
(en)
|
1991-10-11 |
1995-01-27 |
F. Hoffmann-La Roche Ag |
Cyclic vasoactive peptides
|
US5681816A
(en)
|
1992-04-24 |
1997-10-28 |
Korman; Louis Y. |
Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
US5972883A
(en)
|
1993-03-16 |
1999-10-26 |
Yeda Research And Development Co. Ltd. |
Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
US5900405A
(en)
|
1994-01-24 |
1999-05-04 |
Bioelastics Research, Ltd. |
Polymers responsive to electrical energy
|
CA2187322A1
(en)
|
1994-04-07 |
1995-10-19 |
Israel Rubinstein |
Vasoactive intestinal polypeptide
|
US5527610A
(en)
|
1994-05-20 |
1996-06-18 |
The Uab Research Foundation |
Elastomeric polypeptide matrices for preventing adhesion of biological materials
|
US5854387A
(en)
|
1995-04-14 |
1998-12-29 |
Bioelastics Research, Ltd. |
Simple method for the purification of a bioelastic polymer
|
US5972406A
(en)
|
1995-04-14 |
1999-10-26 |
Bioelastics Research Ltd. |
Bioelastomers suitable as food product additives
|
US6004782A
(en)
|
1995-04-14 |
1999-12-21 |
Bioelastics Research Ltd. |
Hyperexpression of bioelastic polypeptides
|
US5624711A
(en)
|
1995-04-27 |
1997-04-29 |
Affymax Technologies, N.V. |
Derivatization of solid supports and methods for oligomer synthesis
|
US6037321A
(en)
|
1995-05-03 |
2000-03-14 |
Biostar Inc. |
Fusion proteins comprising vasoactive intestinal peptide or PACAP
|
JP2000500733A
(ja)
|
1995-09-01 |
2000-01-25 |
ユニバーシティ オブ ワシントン |
相互作用分子結合体
|
US5702717A
(en)
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
DK0929578T3
(da)
|
1996-02-09 |
2003-08-25 |
Abbott Lab Bermuda Ltd |
Humane antistoffer, der binder human TNFalfa
|
WO1997029126A1
(en)
|
1996-02-09 |
1997-08-14 |
F. Hoffmann-La Roche Ag |
Synthesis of vip analog
|
US6063061A
(en)
|
1996-08-27 |
2000-05-16 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US5816259A
(en)
|
1997-01-13 |
1998-10-06 |
Rose; Samuel |
Method for the diagnosis and treatment of cancer by the accumulation of radioactive precipitates in targeted cells
|
US20020099003A1
(en)
*
|
1997-10-28 |
2002-07-25 |
Wilson Leland F. |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
EP1056413A4
(en)
|
1998-02-27 |
2003-08-20 |
Bioelastics Res Ltd |
INJECTABLE IMPLANTS FOR TISSUE ENHANCEMENT AND RESTORATION
|
US6998387B1
(en)
|
1998-03-19 |
2006-02-14 |
Amylin Pharmaceuticals, Inc. |
Human appetite control by glucagon-like peptide receptor binding compounds
|
FR2776520B1
(fr)
|
1998-03-25 |
2000-05-05 |
Sod Conseils Rech Applic |
Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
|
ES2138561B1
(es)
|
1998-04-17 |
2000-07-01 |
Univ Madrid Complutense |
Uso de los peptidos vip y pacap en el tratamiento del shock endotoxico en mamiferos.
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
US20020151458A1
(en)
|
1998-04-17 |
2002-10-17 |
Perez Gomariz Rosa Maria |
Method for treating and preventing septic shock with VPAC1R, VPAC2R and PAC1R agonists
|
US6200598B1
(en)
|
1998-06-18 |
2001-03-13 |
Duke University |
Temperature-sensitive liposomal formulation
|
US6541033B1
(en)
|
1998-06-30 |
2003-04-01 |
Amgen Inc. |
Thermosensitive biodegradable hydrogels for sustained delivery of leptin
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
AU3867400A
(en)
|
1999-03-19 |
2000-10-09 |
Duke University |
Methods of using bioelastomers
|
US20090175821A1
(en)
|
1999-05-17 |
2009-07-09 |
Bridon Dominique P |
Modified therapeutic peptides with extended half-lives in vivo
|
CA2391448A1
(en)
|
1999-11-12 |
2001-05-17 |
Leo Rubin |
Use of vasoactive intestinal peptides and kits therefor
|
US6235264B1
(en)
|
1999-12-01 |
2001-05-22 |
General Electric Company |
Medical imaging method for characterizing tumor angiogenesis using polymeric contrast agents
|
US6593394B1
(en)
|
2000-01-03 |
2003-07-15 |
Prosperous Kingdom Limited |
Bioactive and osteoporotic bone cement
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
US6608174B1
(en)
|
2000-02-18 |
2003-08-19 |
Dabur Research Foundation |
Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
|
US6489297B1
(en)
|
2000-02-18 |
2002-12-03 |
Dabur Research Foundation |
Vasoactive intestinal peptide analogs
|
US20050255554A1
(en)
*
|
2000-03-20 |
2005-11-17 |
Ashutosh Chilkoti |
Fusion peptides isolatable by phase transition
|
US6852834B2
(en)
|
2000-03-20 |
2005-02-08 |
Ashutosh Chilkoti |
Fusion peptides isolatable by phase transition
|
ATE424413T1
(de)
|
2000-06-16 |
2009-03-15 |
Lilly Co Eli |
Analoge des glucagon-ähnlichen peptids-1
|
AU2001273632A1
(en)
|
2000-06-23 |
2002-01-08 |
Drexel University |
Polymeric, fiber matrix delivery systems for bioactive compounds
|
AU2072002A
(en)
|
2000-11-28 |
2002-06-11 |
Mondobiotech Sa |
Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
|
ES2311560T3
(es)
|
2000-12-07 |
2009-02-16 |
Eli Lilly And Company |
Proteinas de fusion glp-1.
|
CN1501809B
(zh)
|
2000-12-13 |
2012-10-10 |
伊莱利利公司 |
应用胰高血糖素样促胰岛肽的长期治疗方案
|
AU2002308706A1
(en)
|
2001-06-01 |
2002-12-16 |
Eli Lilly And Company |
Glp-1 formulations with protracted time action
|
KR100593348B1
(ko)
|
2001-08-23 |
2006-06-26 |
일라이 릴리 앤드 캄파니 |
글루카곤-유사 펩티드-1 유사체
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
CN1315531C
(zh)
|
2001-11-06 |
2007-05-16 |
千寿制药株式会社 |
用于眼睛干燥及与眼睛干燥相关的疾病的治疗剂
|
PT1463751E
(pt)
|
2001-12-21 |
2013-08-26 |
Human Genome Sciences Inc |
Proteínas de fusão de albumina
|
DK1515745T3
(da)
|
2002-06-10 |
2009-07-13 |
Mondobiotech Ag |
Anvendelse af forbindelser med biologiskaktivitet af vasoaktivt intestinalt peptid til behandlingen af sarkoidose
|
WO2004048401A1
(ja)
|
2002-11-27 |
2004-06-10 |
Itoham Foods Inc. |
ペプチド及びこれを含む医薬組成物
|
US20040234609A1
(en)
|
2003-05-14 |
2004-11-25 |
Collier Katherine D. |
Repeat sequence protein polymer active agent congjugates, methods and uses
|
JP2007524592A
(ja)
|
2003-06-03 |
2007-08-30 |
ノボ・ノルデイスク・エー/エス |
安定化された薬学的ペプチド組成物
|
AU2004255379B2
(en)
|
2003-07-14 |
2007-08-16 |
Mondobiotech Ag |
Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections
|
WO2005014030A1
(en)
|
2003-07-24 |
2005-02-17 |
Lutz-Henning Block |
Method for treating lung diseases associated with ventilation-perfusion mismatches
|
US7776815B2
(en)
|
2004-02-24 |
2010-08-17 |
Wisconsin Alumni Research Foundation |
Use of neuropeptides for ligament healing
|
US7928059B2
(en)
|
2004-02-24 |
2011-04-19 |
Wisconsin Alumni Research Foundation |
Use of neuropeptides for traumatic cartilage injury
|
US20050203009A1
(en)
|
2004-03-12 |
2005-09-15 |
Bayer Pharmaceuticals Corporation |
VPAC1 selective antagonists and their pharmacological methods of use
|
US7803764B2
(en)
|
2004-03-29 |
2010-09-28 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Amphipathic glycopeptides
|
EP1753780B1
(en)
*
|
2004-05-21 |
2008-03-19 |
Eli Lilly And Company |
Selective vpac2 receptor peptide agonists
|
CN1993137B
(zh)
|
2004-06-11 |
2015-04-22 |
维克特斯生物***有限公司 |
用于治疗心血管疾病的组合物和方法
|
CN101001639A
(zh)
*
|
2004-06-12 |
2007-07-18 |
拜尔药品公司 |
血管活性肠肽(vip)/垂体腺苷酸环化酶活化肽(pacap)受体2(vpac2)激动剂的聚乙二醇化和使用方法
|
US20080085860A1
(en)
*
|
2004-08-18 |
2008-04-10 |
Eli Lilly And Company |
Selective Vpac2 Receptor Peptide Agonists
|
US20080146500A1
(en)
*
|
2004-08-18 |
2008-06-19 |
Bengt Krister Bokvist |
Selective Vpac2 Receptor Peptide Agonists
|
EP1804820A4
(en)
|
2004-10-08 |
2009-12-02 |
Transition Therapeutics Inc |
PHARMACEUTICAL PRODUCTS BASED ON VASOACTIVE INTESTINAL POLYPEPTIDES
|
US7723472B2
(en)
|
2005-02-28 |
2010-05-25 |
The Regents Of The University Of California |
Extracellular matrix binding chimeric proteins and methods of use thereof
|
JP5253159B2
(ja)
|
2005-06-24 |
2013-07-31 |
デューク・ユニヴァーシティ |
熱応答性バイオポリマーに基づく直接的ドラッグデリバリーシステム
|
WO2007050651A1
(en)
*
|
2005-10-26 |
2007-05-03 |
Eli Lilly And Company |
Selective vpac2 receptor peptide agonists
|
AU2006314037B2
(en)
|
2005-11-18 |
2010-09-23 |
Dabur Pharma Limited |
Targeted fusion proteins for cancer therapy
|
NZ604248A
(en)
|
2005-12-09 |
2014-07-25 |
Vectus Biosystems Ltd |
Vip fragments and methods of use
|
US8841255B2
(en)
|
2005-12-20 |
2014-09-23 |
Duke University |
Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
|
ES2779992T3
(es)
*
|
2005-12-20 |
2020-08-21 |
Univ Duke |
Métodos y composiciones para suministrar agentes activos con propiedades farmacológicas potenciadas
|
US8367626B2
(en)
*
|
2006-05-12 |
2013-02-05 |
Wisconsin Alumni Research Foundation |
Elastin-like polymer delivery vehicles
|
AU2007292295B2
(en)
|
2006-09-06 |
2013-06-06 |
Immunoforge Co., Ltd. |
Fusion peptide therapeutic compositions
|
CA2687602C
(en)
|
2007-05-21 |
2014-07-15 |
Res International Sarl |
Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases
|
JP2010536341A
(ja)
|
2007-08-15 |
2010-12-02 |
アムニクス, インコーポレイテッド |
生物学的に活性なポリペプチドの特性を改変するための組成物および方法
|
EP2307038A4
(en)
|
2008-06-27 |
2013-03-27 |
Univ Duke |
THERAPEUTIC AGENTS COMPRISING ELASTINE-LIKE PEPTIDES
|
ES2532138T3
(es)
|
2008-10-23 |
2015-03-24 |
Vertex Pharmaceuticals Incorporated |
Moduladores del regulador de la conductancia transmembrana de la fibrosis quística
|
WO2010080578A1
(en)
*
|
2008-12-18 |
2010-07-15 |
Phasebio Pharmaceuticals, Inc. |
Biologically active proteins activatable by peptidase
|
MX366935B
(es)
*
|
2009-08-14 |
2019-07-31 |
Phasebio Pharmaceuticals Inc |
Peptidos intestinales vasoactivos modificados.
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
ES2669190T3
(es)
|
2011-06-06 |
2018-05-24 |
Phasebio Pharmaceuticals, Inc. |
Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión
|
US9605186B2
(en)
|
2012-09-19 |
2017-03-28 |
Exxonmobil Chemical Patents Inc. |
Adhesive compositions of ethylene-based and propylene-based polymers
|
CA2947982C
(en)
|
2014-05-08 |
2022-11-29 |
Phasebio Pharmaceuticals, Inc. |
Methods and compositions for treating cystic fibrosis
|